Vaccination-related adverse events

Franz E Babl1, Stuart Lewena, Lance Brown

  • 1Emergency Department, Royal Children's Hospital and Murdoch Children's Research Institute, Melbourne, Australia. ranz.babl@rch.org.au

Insights

Vaccine adverse events are rare and usually mild. This review helps clinicians identify and manage events possibly linked to routine immunizations, ensuring future vaccine safety.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Vaccine-related adverse events are uncommon and typically mild.
  • Children may experience various conditions post-immunization, requiring clinical evaluation.
  • Determining causality is crucial for ongoing vaccine safety and future administration.

Purpose of the Study:

  • To review current understanding of vaccine-related adverse events.
  • To equip clinicians with information to differentiate vaccine-related from unrelated events.
  • To discuss appropriate management strategies for adverse events following immunization.

Main Methods:

  • Literature review of vaccine-related adverse events.
  • Analysis of clinical presentations following routine immunizations.
  • Discussion of diagnostic criteria and management protocols.

Main Results:

  • Most vaccine adverse events are mild (e.g., rashes, fever).
  • Specific events like seizures or protracted crying can occur post-vaccination.
  • Distinguishing causal relationships requires careful clinical assessment.

Conclusions:

  • Clinicians can identify likely vaccine-related adverse events.
  • Accurate identification impacts future vaccine recommendations and patient care.
  • Effective management strategies are essential for addressing post-vaccination events.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...